Abstract 4259: PT199, a next generation anti-CD73 mAb that inhibits both membrane-bound and soluble CD73 activity to completion without “hook effect”

Haiqun Jia, Hui Zou, Jessica Perer, Lauren Pejza, Kelan Chen(Clover Biopharmaceuticals (China)), Long Yan(Army Medical University), Ming Wang(Wenzhou Medical University), Fen Pei, Jack Li(FibroGen (United States)), L.N. Greenwood
Cancer Research
June 15, 2022
Cited by 4


Related Papers